1. Market Research
  2. > Pharyngitis - Pipeline Review, H1 2013

Pharyngitis - Pipeline Review, H1 2013

  • June 2013
  • -
  • Global Markets Direct
  • -
  • 26 pages

Pharyngitis - Pipeline Review, H1 2013


Summary


Global Markets Direct’s, 'Pharyngitis - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Pharyngitis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Pharyngitis. Pharyngitis - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


Scope


- A snapshot of the global therapeutic scenario for Pharyngitis.
- A review of the Pharyngitis products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
- Coverage of the Pharyngitis pipeline on the basis of route of administration and molecule type.
- Key discontinued pipeline projects.
- Latest news and deals relating to the products.


Reasons to buy


- Identify and understand important and diverse types of therapeutics under development for Pharyngitis.
- Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
- Plan mergers and acquisitions effectively by identifying players of the most promising pipeline.
- Devise corrective measures for pipeline projects by understanding Pharyngitis pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.

Table Of Contents

Pharyngitis - Pipeline Review, H1 2013
Table of Contents 2
List of Tables 3
List of Figures 3
Introduction 4
Global Markets Direct Report Coverage 4
Pharyngitis Overview 5
Therapeutics Development 6
An Overview of Pipeline Products for Pharyngitis 6
Pharyngitis Therapeutics under Development by Companies 8
Late Stage Products 9
Comparative Analysis 9
Pharyngitis Therapeutics - Products under Development by Companies 10
Companies Involved in Pharyngitis Therapeutics Development 11
Zambon Group S.p.A. 11
BioStar Pharmaceuticals, Inc. 12
Pharyngitis - Therapeutics Assessment 13
Assessment by Monotherapy Products 13
Assessment by Route of Administration 14
Assessment by Molecule Type 16
Drug Profiles 18
azithromycin - Drug Profile 18
Product Description 18
Mechanism of Action 18
RandD Progress 18
Pharyngitis Therapeutics - Dormant Products 19
Pharyngitis - Product Development Milestones 20
Featured News and Press Releases 20
Mar 17, 2010: MiddleBrook Pharmaceuticals Announces Expanded Increase Rx Promotion for Moxatag 20
Feb 03, 2010: MiddleBrook Announces Promotion Partnership Of MOXATAG Tablets With DoctorDirectory.com For The Treatment Of Tonsillitis And Pharyngitis 20
Feb 03, 2010: MiddleBrook Pharmaceuticals Announces Promotion Partnership with DoctorDirectory.com for Moxatag (extended-release amoxicillin) Tablets, 775mg 20
Oct 12, 2009: Moxatag Supports Health Education on FamilyDoctor.org 21
Jul 15, 2009: MiddleBrook Pharmaceuticals Announces $20 Maximum Copay Program for Moxatag 21
May 01, 2009: MiddleBrook Pharmaceuticals Launches Moxatag Website, Announces Early Prescription Data for Moxatag 22
Mar 16, 2009: MiddleBrook Pharmaceuticals Launches Moxatag, the First and Only FDA-Approved Once-Daily Amoxicillin 22
Feb 04, 2009: MiddleBrook Pharmaceuticals Retains Almac Pharma Services to Produce Physician Samples of Moxatag 23
Jan 07, 2009: MiddleBrook Pharmaceuticals to Launch Moxatag March 2009 23
Nov 06, 2008: MiddleBrook Pharmaceuticals Announces Orange Book Listing of Moxatag Patents 24
Appendix 25
Methodology 25
Coverage 25
Secondary Research 25
Primary Research 25
Expert Panel Validation 25
Contact Us 26
Disclaimer 26

List of Tables


Number of Products Under Development for Pharyngitis, H1 2013 6
Products under Development for Pharyngitis - Comparative Analysis, H1 2013 7
Number of Products under Development by Companies, H1 2013 8
Comparative Analysis by Late Stage Development, H1 2013 9
Products under Development by Companies, H1 2013 10
Zambon Group S.p.A., H1 2013 11
BioStar Pharmaceuticals, Inc., H1 2013 12
Assessment by Monotherapy Products, H1 2013 13
Assessment by Stage and Route of Administration, H1 2013 15
Assessment by Stage and Molecule Type, H1 2013 17
Pharyngitis Therapeutics - Dormant Products 19

List of Figures


Number of Products under Development for Pharyngitis, H1 2013 6
Products under Development for Pharyngitis - Comparative Analysis, H1 2013 7
Products under Development by Companies, H1 2013 8
Late Stage Products, H1 2013 9
Assessment by Monotherapy Products, H1 2013 13
Assessment by Route of Administration, H1 2013 14
Assessment by Stage and Route of Administration, H1 2013 15
Assessment by Molecule Type, H1 2013 16
Assessment by Stage and Molecule Type, H1 2013 17

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

ref:plp2013

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.